Notice: This company recently went public with an IPO on Tuesday, January 28th 2025. They issued 20,000,000 shares at $10.00 per share. We will continue to update data for DMAAU as it becomes available. Drugs Made in America Acquisition (DMAAU) Competitors $10.02 +0.02 (+0.20%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsTrends DMAAU vs. AGBAW, AGNCP, AGNCO, AGNCN, AGNCM, AGNCL, ANSCW, ANSCU, AITRU, and AITRRShould you be buying Drugs Made in America Acquisition stock or one of its competitors? The main competitors of Drugs Made in America Acquisition include AGBA Group (AGBAW), AGNC Investment (AGNCP), AGNC Investment (AGNCO), AGNC Investment (AGNCN), AGNC Investment (AGNCM), AGNC Investment (AGNCL), Agriculture & Natural Solutions Acquisition (ANSCW), Agriculture & Natural Solutions Acquisition (ANSCU), AI Transportation Acquisition (AITRU), and AI Transportation Acquisition (AITRR). These companies are all part of the "trading" industry. Drugs Made in America Acquisition vs. AGBA Group AGNC Investment AGNC Investment AGNC Investment AGNC Investment AGNC Investment Agriculture & Natural Solutions Acquisition Agriculture & Natural Solutions Acquisition AI Transportation Acquisition AI Transportation Acquisition AGBA Group (NASDAQ:AGBAW) and Drugs Made in America Acquisition (NASDAQ:DMAAU) are both financial services companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, earnings, risk, community ranking, dividends, media sentiment, valuation, analyst recommendations and profitability. Which has better valuation & earnings, AGBAW or DMAAU? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAGBA Group$38.55MN/AN/AN/AN/ADrugs Made in America AcquisitionN/AN/AN/AN/AN/A Does the media favor AGBAW or DMAAU? In the previous week, Drugs Made in America Acquisition had 5 more articles in the media than AGBA Group. MarketBeat recorded 5 mentions for Drugs Made in America Acquisition and 0 mentions for AGBA Group. Drugs Made in America Acquisition's average media sentiment score of 0.30 beat AGBA Group's score of 0.00 indicating that Drugs Made in America Acquisition is being referred to more favorably in the news media. Company Overall Sentiment AGBA Group Neutral Drugs Made in America Acquisition Neutral Is AGBAW or DMAAU more profitable? Company Net Margins Return on Equity Return on Assets AGBA GroupN/A N/A N/A Drugs Made in America Acquisition N/A N/A N/A Does the MarketBeat Community prefer AGBAW or DMAAU? AGBA Group and Drugs Made in America Acquisition both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformAGBA GroupN/AN/ADrugs Made in America AcquisitionN/AN/A SummaryDrugs Made in America Acquisition beats AGBA Group on 2 of the 3 factors compared between the two stocks. Get Drugs Made in America Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for DMAAU and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DMAAU vs. The Competition Export to ExcelMetricDrugs Made in America AcquisitionInvestment Offices IndustryFinance, Insurance, And Real Estate SectorNASDAQ ExchangeMarket CapN/A$112.96M$10.55B$9.15BDividend YieldN/AN/A0.85%3.98%P/E RatioN/AN/A2.6317.66Price / SalesN/AN/A16.8781.08Price / CashN/AN/AN/A37.71Price / BookN/AN/AN/A4.73Net IncomeN/AN/AN/A$225.42M7 Day PerformanceN/A0.44%0.71%-0.44%1 Month PerformanceN/A2.02%2.81%3.57%1 Year PerformanceN/A0.99%15.35%19.20% Drugs Made in America Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DMAAUDrugs Made in America AcquisitionN/A$10.02+0.2%N/AN/A$0.00N/A0.002News CoverageAGBAWAGBA GroupN/A$0.20+0.1%N/A+1,531.6%$0.00$38.55M0.00152Gap UpAGNCPAGNC InvestmentN/A$24.76+0.0%N/A+7.8%$0.00$1.26B0.0050Short Interest ↓News CoverageNegative NewsAGNCOAGNC InvestmentN/A$25.44flatN/A+4.6%$0.00$1.26B0.0050Short Interest ↓News CoverageAGNCNAGNC InvestmentN/A$25.82-0.3%N/A+0.9%$0.00$1.26B0.0050Short Interest ↑News CoverageAGNCMAGNC InvestmentN/A$25.21-0.4%N/A+4.0%$0.00$1.26B0.0050Short Interest ↓News CoverageAGNCLAGNC InvestmentN/A$24.38-0.2%N/A+9.1%$0.00$1.26B0.0050Short Interest ↓News CoverageANSCWAgriculture & Natural Solutions AcquisitionN/A$0.36+8.2%N/AN/A$0.00N/A0.00N/APositive NewsGap UpANSCUAgriculture & Natural Solutions AcquisitionN/A$10.67+0.7%N/A+6.1%$0.00N/A0.00N/APositive NewsAITRUAI Transportation AcquisitionN/A$11.08+1.6%N/A+14.3%$0.00N/A0.00N/APositive NewsAITRRAI Transportation AcquisitionN/A$0.14+38.6%N/A-15.8%$0.00N/A0.00N/A Related Companies and Tools Related Companies AGBA Group Competitors AGNC Investment Competitors AGNC Investment Competitors AGNC Investment Competitors AGNC Investment Competitors AGNC Investment Competitors Agriculture & Natural Solutions Acquisition Competitors Agriculture & Natural Solutions Acquisition Competitors AI Transportation Acquisition Competitors AI Transportation Acquisition Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:DMAAU) was last updated on 1/30/2025 by MarketBeat.com Staff From Our PartnersHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredTrump vs. TexasEver since Donald Trump won the election, U.S. states have been rushing to pass new currency rules. These r...Stansberry Research | SponsoredTrump’s New AI Move Could Trigger Massive Melt UPIn his first week in office, President Trump already revoked President Biden's disastrous AI executive order.....InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Drugs Made in America Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Drugs Made in America Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
